register

News & Trends - Biotechnology

‘Innovation makes a real and measurable difference to people’s lives at their most vulnerable time’, says Noxopharm CEO: National Science Week

Health Industry Hub | August 16, 2023 |

Biotech News: Embarking on the next chapter of our interview series celebrating National Science Week, Dr Gisela Mautner, CEO and Managing Director of Australian biotech company Noxopharm delved into the intersection between innovation and the dynamic healthcare landscape.

At the heart of our conversation was the National Science Week theme, Innovation: Powering Future Industries. Dr Mautner’s articulation of her personal passion for STEM underscored the profound alignment between her dedication and the overarching theme.

“Innovation in the development of new technologies is absolutely central to bridging the gaps that we have in the current healthcare system, to be able to improve patients’ lives. This is why I’m so excited about STEM as it’s a relentless push of current boundaries. I feel it makes a real and measurable difference to people’s lives, and specifically to people’s lives at their most vulnerable time when they’re sick,” she stated.

Turning our attention to recent events, Dr Mautner shared the key highlights from the BIO International Convention. These highlights seamlessly converged with Noxopharm’s pioneering research pursuits, underscoring the organisation’s commitment to steering healthcare innovation toward new horizons.

Anticipating the future, Dr Mautner shared her perspectives on the forthcoming RNA Leaders Congress in Boston. Her observations regarding the conference’s alignment with the National Science Week theme emphasised the enduring impact of innovation as an enabler of progress within healthcare.

In reflecting upon the year so far, Dr Mautner shared a thoughtful evaluation of the accomplishments that resonate most profoundly. Her insights unveil strategic milestones that underscore Noxopharm’s pivotal contribution to shaping the trajectory of innovation in healthcare.

Reimagining healthcare across the entire patient journey: Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.

The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.